FDA NDC Directory · JSON-LD · Markdown

CIMERLI

NDC 70114-441 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameranibizumab-eqrn
Labeler / ManufacturerCoherus BioSciences Inc
Marketing categoryBiologic License Application · App BLA761165
Dosage form / routeINJECTION, SOLUTION · INTRAVITREAL
Active ingredientsRANIBIZUMAB (.5 mg/.05mL)
Marketing started20221003
Marketing ended20270131
Package count1

External sources

Source: openFDA. Public-domain (CC0).